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   The effect of chlorpromazine (Chp), ether, hexobarbital (evipal) and 
urethan on the content and turnover rate of phosphate compounds in rat 
brain tissue was investigated. 32P was taken up into various phosphate 
fractions in the following order of decreasing rate: ATP, creatine phos-
phate (CP), nucleoprotein (NP) and phospholipid (LP). ATP concentration 
was increased and the turnover rate of the fraction was diminished by 
Chp with evipal (Chp-evipal) and Chp with urethan (Chp-urethan) anes-
thesia. CP concentration was not appreciably changed but its turnover rate 
was decreased except for Chp with ether (Chp-ether) anesthesia in which 
a reduction of CP and acceleration of its turnover rate was noted. These 
findings suggest that the utilization of high energy phosphate esters is 
inhibited by Chp-evipal and Chp-urethan but not by Chp-ether. The incor-
poration of 32P into LP and NP was significantly decreased after 2-hour 
anesthesia, while it was rather increased within 30 minutes particularly 
with Chp-ether anesthesia. A different mode of action of Chp-ether on 
phosphate metabolism of the brain is suspected when compared with that 
of Chp-evipal as well as Chp-urethan.
   The significance of phosphate metabolism in the brain activity has been the 
subject of controversy. Recent evidence has been presented that the incorporation 
of 32P into organic phosphate esters in the brain is more rapid than in the muscle 
(LINDBERG and ERNSTERLO ), and a constant renewal of phosphates occurs even in 
the fraction of pnospholipid as well as nucleoprotein of the brain tissue (CHAIKOFF3 ) ). 
    The possibility that the content and turnover rate of phosphate compounds may
be changed by depression of the central nervous system offers pharmacological interest 
in studies on the mode of action of anesthetic drugs. While it has been reported that 
the metabolism of inorganic phosphate and organic esters are affected by barbiturates 
(STONTE1", LE PAGE", NAKAL1'), KOZAWA8)) and chlorpromazine (GRENELL°), GRI-
SW AI D7 ), OGAwA12) ), precise information on the turnover rate of various phosphate 
fractions is still lacking. 
    In the present experiments the phosphate compounds of the brain in rats were 
analyzed and a turnover rate of 32P in each fraction was determined simultaneously. 
The values of controls were statistically compared with those of rats anesthetized with 
chlorpromazine (Chp), ether, hex barbital (evipal) and urethan.
METHODS
White rats of either sex weighing from 150 to 200g were divided into five
*I Reported in Folia pharmacol . jap. 55: 1430 (1959) in Japanese.
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groups. The rats of the first group were not anesthetized and served as controls. 
The second group was given 20 mg/kg of Chp alone intramuscularly. The third, forth 
and fifth one receiving ether, evipal or urethan combined with Chp referred to the 
group of Chp-ether, Chp-evipal and Chp-urethan, respectively. The radioisotope solu-
tion containing about 20 ft c of 32P was injected into the subarachnoid space of the 
rat brain by the method described by LINDBERG and ERNSTER'0). When convulsion, 
paralysis or other severe lesions were encountered, the animals were rejected. 
    In order to prevent post-mortem decomposition of organic phosphate compounds, 
particularly labile phosphate esters, liquid air was employed for freezing the tissue. 
The head of the animal was drowned in liquid air and frozen within a few seconds. 
The frozen brain was removed and weighed quickly. Under continuous cooling with 
the use of an ice-salt mixture, the brain was taken into a mortar and ground with 
10 cc of 10 per cent trichloroacetic acid solution. After standing for about 10 minutes, 
the suspension was centrifuged at 2500 rpm by means of refrigerated centrifuge. The 
supernatant solution refers to an acid soluble phosphate (TP) fraction. An aliquot 
was transferred to the centrifuge tube and then a maTuesia mixture was added. After 
standing overnight in a refrigerator, the precipitate containing inorganic phosphate (IP) 
fraction was removed. The supernatant solution was adjusted to 0.2N by HNO3, 
ammonium molybdate was added and left standing for 1.5 hours in a refrigerator to 
obtain the precipitate containing the creatine phosp-ate (CP) fraction. The superna-
tant solution adjusted to 0.5N by HNO3 was boiled for 15 minutes and readjusted 
to 0.2N by NH4OI-I. After standing with the ammonium molybdate solution, the 
precipitate containing the ATP fraction was removed. 
   A phospholipid (LP) fraction was extracted from the residue by rerluxing twice 
with 10 cc of 80 per cent alcohol and then three times with an alcohol-ether mixture 
boiled gently. The ultimate residue refers to the nucleoprotein (NP) fraction. 
   Each organic phosphate fraction was placed in a small Kjeldahl flask and brought 
into solution by digestion with ION H2 SO, and a few drops of H2 01. An aliquot 
was analyzed for phosphate by the method of FISKE and SUBBAROW". 
    Radioactivity was measured using a Geiger-Muller counter. The specific activity 
was given as the counts per minute of 32P divided by the number of mg of phos-
phate. The relative specific activity indcating the turnover rate of a fraction was 
represented by a ratio (x 1000) of its specific activity to that of the precursor. Inorganic 
phosphate was taken as the precursor of creatine phosphate as well as ATP, and the 
total acid soluble phosphate was of phospholipid and nucleoprotein.
RESULTS
    1. Control 
   The rats of this group were not anesthetized but 0.1 cc of 32P solution was 
injected into the subarachnoid space. The analysis of the brain was carried out 30 
minutes as well as 2 hours after administration of the radioisotope solution. 
   Table 1 shows the phosphate values of IP, CP, ATP, LP and NP fraction. 
There was no significant difference between the 30-minute and the 2-hour experi-
ment. The findings indicate that phosphate metabolism of the brain was not affected 
by injecting 32P solution. 
   The relative specific activity of 32P in IP, CP, ATP, LP and NP fraction was 
given in table 2. The renewal rate of phosphate fraction was shown in the follow-
ing order of decreasing rate : ATP, CP, NP and LP. The renewal rate of ATP
TABLE 1. Phosphorous Content of the Phosphate Fractions in Rat Brain Tissue
i 
    Drug Time IF mg°o CP mgATP mg,°o TP mg°o LP mg% NP mg% 
Control 30min * 30.2±15.3(7)T: 6.7± 2.6(7) 26.3± 5.8(7) 85.2± 8.5(7) 196.8±33.7(7) 72.0±17.4(7) 
           _ 2 hrs_ 31.4±12.4(7) 4.3± 1.4(7) ; 23.2± 7.0(7) ! 89.8±10.2(7) 174.9±30.3(7) 72.1±16.5(7) 
               30min 32.3±11.4(6) 7.7± 6.2(6) 27.7± 6.9(6) 86.3±11.6(6) 192.2±24.9(6) 71.4±11.6(6) Chlorpromazine 
               2 hrs 34.9± 9.1(7) 4.6± 1.6(6)_; 24.4± 7.2(7) 89.9± 6.3(7) 191.5±15.5(7) 71.0± 9.6(7) 
Chp ether 30min 33.2± 5.7(4) 1.8± 0,4(4) 26.3± 3.8(4) I 80.7± 9.0(7) 195.9±11.6(7) 56.3.±10.6(7) 
             _, 2 hrs 26.0± 3.6(4) 2.7± 0.7(3) 30.9± 3.6(4) 72.4±12.1(4) 185.5±17.1(4) 59.5± l.l(4) 
               30min 28.5± 2.5(4) 3.6± 0.5(4) 33.8± 7.8(4) 85.7± 7.5(7) 194.6±16.8(7) 61.5± 2.2(4) Chp-evipal 
                2 hrs 37.1± 8.5(4) 7.8± 1.1(4) 33.4± 6.6(4) 85.3± 5.0(4) _ 186.7±22.5(4) 57.5± 5.7(4) 
Chp-urethan 30min 38.1± 7.4(4) 4.0± 0.7(4) 34.9±14.0(4) 84.8± 5.1(4) 193.0±20.4(4) 61.5± 9.1(4) 
               2 hrs j 26.8± 5.1(4) 6.0± 1.1(3) 34.3± 3.5(4) 81.5± 4.5(4) 190.3± 9.0(4) 58.8± 5.5(4)
* Values expressed mean ±, "x12-Nx2 1' Numbers in parenthesis are number of animals employed .                         N-1
TABLE 2. Relative Specific Activity of the Phosphate Fractions in Rat Brain Tissue
                                 
'. I I 
     Drug Time I CID j ATP LP NP 
          
I I I ~ I 
                30min I* 252.6±185.4(6)tt 777.6±451.7(6) 314±11.3(7) 154.5±42.0(7)  Control 
_ 2 hrs 460.7±100,6(5) 1 838.1±121.9(7)_ 70.5±23.4_(7) 279.3±72.0(7) 
 Chlorpromazine 30min III 228.9±170.7(6) 462.8±324.1(6) 27.4± 7.9(6) 130.5±34.8(6) 
              _j 2 hrs 263.5± 98.1(5) 1 849.0±465.5(7) _ 38.1± 8.1(7) 187.5±_47.3(7) 
 Chp ether 30min 1182.0± 555.3(4)1 717.2± 91.6(4) 46.8±23.9(7) 327.2±67.0(7) 
               2 hrs j 1349.3±1053.8(3)) 859.0±255.2(4) , 37.5± 2.9(4) 199.9±42.7(4) 
 Chp evipal 30min 138.4± 39.6(4)'1 68.8± 57.0(4) 49.3±15.6(7) 80.5±22.6(4) 
                2 hrs 78.2± 43.1(4)1 134.2± 53.3(4) 35.2± 6.1(4) 205.9±29.4(4) 
 Chp urethan 30min 196.4± 149.6(4)' 193.1±134.2(4) 10.5± 1.6(4) 134.5±55.0(4) 
                2 hrs 216.7± 147.0(3)I 250.6± 21.9(4) 14.0± 4.4(4) 92.1±18.8(4)
                        F.X12-NX2 Valu
es expressed mean± ,, - N_l . Numbers in parenthesis are number of animals employed,
attained 80 per cent within 30 minutes and very gradual increase occurred thereafter. 
Other fractions showed rather slow renewal rate within 30 minutes but attained 
twice after 2 hours. 
   2. Effect of Chp 
    Prior to the administration of 82P solution, the rats were given 20 mg/kg of 
Chp intramuscularly. The phosphate values of IP, CP, ATP, LP and NP fraction 
are shown in table 1. When compared with the controls the phosphate levels in 
the experimental group showed no appreciable change. 
   The relative specific activity is presented in table 2. It was found that ATP 
in the 30-minute and CP in the 2-hour experiment were significantly (P<0.05) 
lower than the controls. The decrease of LP and NP in the 2-hour experiment 
was also statistically significant (P<0.01). 
   3. Effect of Chp-ether anesthesia 
    The stage of anesthesia was maintained approximately at surgical level by 
controlling the amount of ether applied to the animal. As can be seen in table 1, 
the phosphate level of the CP and ATP fractions in the 30-minute experiment was 
significantly lower (P<0.05) than in the controls as well as in the rats receiving 
Chp alone. Contray to the above fraction, the phosphate level of ATP was signifi-
cantly higher (P<0.05) than in the controls and Chp-treated rats. 
   While there was no appreciable change in the relative specific acivity of ATP, 
that of CP was diminished. (P<0.01) in the 30-minute as well as in the 2-hour 
experiment. In LP and NP fractions the relative specific activities were elevated 
within 30 minutes but after 2 hours they were decreased significantly (P<0.01). 
   4. Effect of Chp-evipal anesthesia 
   In this experiment the animal was given 50 mg/kg of evipal combined with 
Chp. Table 1 shows the phosphate level and table 2, the relative specific activity of 
each fraction. The phosphate level of IP, CP and LP fractions were not significantly 
altered. An increase of phosphate level in the ATP fraction was significant com-
pared to the controls (P<0.01) and the Chp-treated. rats (P<0.05). In the NP 
fraction a significant (P<0.05) decrease was noted. 
   The relative specific activity of the ATP fraction was smaller than the controls 
in the 30-minute (P<0.05) as well as in the 2-hour experiment (P<0.01), that of 
the CP fraction also being lowered in the 2-hour experiment. While the relative 
specific activity of the LP fraction was higher "P<0.05) within 30 minutes, after 
2 hours it was significantly (P<0.01) reduced. 
   5. Effect of Chp-urethan anesthesia 
   After the Chp was given, additional injection of 1.0 g/kg of urethan was made 
intramuscularly. Table 1 shows that the phosphate level of the IP, CP and LP frac-
tions was not appreciably changed. There was, however, a significant increase (P< 0.01) 
of ATP fraction. in the 2-hour experiment. The phosphate level of the NP fraction 
was lower (P < 0.05) than the controls as well as the Chp-treated animals. 
   The relative specific activity of ATP (P<0.01) and N P (P<0.05) fractions in 
the 30-minute experiment and that of the CP (P<0.05), ATP (P<0.01), LP (P<0.01) 
and N P (P<0.01) fractions in the 2-hour experiment were significantly decreased.
DISCUSSION
An accumulation of high energy phosphate esters may be expected when brain
activity is depressed by anesthetic agents, the utilization of these esters being inhibited. 
It holds true that an accumulation of a fraction in the metabolic pathway results in 
a reduction of its renewal rate. The evidence derived from the present experiments, 
that ATP fraction is increased and that the turnover rate of the fraction is signifi-
cantly reduced, appears to be in favor of this view. 
   The findings reported by GRENELL" and KOZAWAB) that IP fraction is de-
creased while CP fraction is increased by Chp and barbiturates, are not confirmed in 
the present studies. It is evident that the turnover rate of this fraction is reduced 
by Chp-e-.:ripal and Chp-urethan anesthesia. Unlike these anesthetics, Chp-ether 
produced a characteristic change in the CP fraction. This was somewhat decreased 
and the renewal rate was augmented. This fact may suggest that the utilization of 
the fraction is accelerated by Chp-ether anesthesia. 
    As emphasized by BRODY2 ) the concentration of energy-rich compounds in the 
brain is the net result of the generation and utilization of these compounds. A reduced 
renewal rate represents not only an inhibited utilization but also generation of the 
fraction. The changes in the content and renewal rate of these compounds are not 
necessarily the same under anesthasia but probably depend upon anesthetic agents 
employed. 
   Although the phosphate level of the LP fraction was not appreciably affected, 
the renewal rate of the fraction appears to be increased during the early stage of 
Chp-ether and Chp-urethan anesthesia. However, after 2 hours the incorporation of 
32P into this fraction is uniformly reduced by all anesthetics employed . The 
finding are in agreement with those reported by WASE et at. ' 4 and DAWSON and 
RICHTER". The turnover rate of the NP fraction was significantly decreased except 
in the case of Chp-ether anesthesia in which an increase was observed in the 
30-minute experiment. These results indicate that anesthetic drugs affect not only 
the metabolism of high-energy phosphate esters but also of structural phospholipid 
and nucleoprotein (AB OD" ). In this respect Chp-ether shows a quite different 
mode of action compared to that of Chp-evipal and Chp-urethan.
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